TREATMENT
Topical aqueous 2% lignocaine eardrops reduced ear pain in children with acute otitis media
| The first 150 words of the full text of this article appear below. |
F E Babl
Dr F E Babl, Royal Childrens Hospital, Parkville, Victoria, Australia; franz.babl@rch.org.au
Are topical aqueous 2% lignocaine (lidocaine) eardrops effective for relieving ear pain in children with acute otitis media (AOM)?
Design: randomised placebo controlled trial.
Allocation: {concealed}.*
Blinding: blinded (children, parents, clinicians administering treatment, and outcome assessors).
Follow-up period: primary outcome was assessed at 10, 20, and 30 minutes.
Setting: emergency department (ED) of a childrens hospital in Australia.
Patients: 63 children 3–17 years of age (mean age 6 y, 51% girls) who had ear pain lasting <3 days and signs of AOM (tympanic membrane with erythema, dullness, and bulging appearance). Children with evidence of tympanic membrane perforation, ventilation tubes in situ, allergy to local anaesthetic or paracetamol, epilepsy, or liver, renal, or cardiac disease were excluded.
Intervention:
3 drops of topical aqueous 2% lignocaine (n = 31) or placebo (saline) (n = 32) instilled in the
Department of Nursing Education, George Washington University, Washington, DC, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
